Cardiac Muscle Insufficiency – Causes, Symptoms & Treatment

What is Cardiac Muscle Insufficiency?

Cardiac muscle insufficiency, commonly known as heart failure, is a serious medical condition in which the heart muscle (myocardium) is no longer able to pump sufficient blood to meet the body demands for oxygen and nutrients. The pumping capacity of the heart is reduced, resulting in inadequate perfusion of organs and tissues. The condition may develop gradually over time or arise suddenly and affects millions of people worldwide.

Causes

Cardiac muscle insufficiency can be triggered by a wide range of underlying conditions and risk factors:

• Coronary artery disease (CAD): Narrowing of the coronary arteries, which can lead to a heart attack and cause permanent damage to the heart muscle.
• High blood pressure (hypertension): Chronically elevated blood pressure places excessive strain on the heart muscle, causing it to thicken and weaken over time.
• Cardiomyopathy: Diseases of the heart muscle itself, such as dilated or hypertrophic cardiomyopathy.
• Heart valve disorders: Malfunctioning heart valves that overload the heart muscle.
• Cardiac arrhythmias: Persistent arrhythmias such as atrial fibrillation can chronically impair pumping performance.
• Inflammation: Myocarditis (inflammation of the heart muscle), for example following a viral infection, can cause significant myocardial damage.
• Other factors: Diabetes mellitus, alcohol and substance abuse, chemotherapy, or congenital heart defects.

Symptoms

The symptoms of cardiac muscle insufficiency depend on the severity of the condition and which side of the heart is primarily affected. Common symptoms include:

• Breathlessness (dyspnea): Initially only during physical exertion, later also at rest or when lying flat (orthopnea).
• Fatigue and exhaustion: Even minor physical activity causes significant tiredness.
• Fluid retention (edema): Swelling of the legs, ankles, or abdomen (ascites).
• Rapid or irregular heartbeat (palpitations).
• Unexplained weight gain due to fluid accumulation.
• Coughing and wheezing due to pulmonary congestion (left-sided heart failure).
• Pallor or cyanosis (bluish discoloration of the lips or fingernails).

Diagnosis

The diagnosis of cardiac muscle insufficiency is based on a combination of clinical assessment and diagnostic investigations:

• Medical history and physical examination: Evaluation of symptoms, risk factors, and auscultation of the heart and lungs.
• ECG (electrocardiogram): Detection of arrhythmias and signs of a previous myocardial infarction.
• Echocardiography: Ultrasound imaging of the heart to assess pumping function (ejection fraction) and cardiac structure.
• Blood tests: Measurement of BNP or NT-proBNP (biomarkers for heart failure), as well as kidney and liver function tests.
• Chest X-ray: Assessment of heart size and pulmonary congestion.
• Cardiac MRI: Detailed imaging of the heart muscle, including detection of scarring or inflammation.
• Cardiac catheterization: Evaluation of the coronary arteries if coronary artery disease is suspected.

Treatment

The treatment of cardiac muscle insufficiency is multimodal and aims to relieve symptoms, slow disease progression, and improve quality of life.

Pharmacological Treatment

• ACE inhibitors or ARBs (angiotensin receptor blockers): Reduce the workload of the heart and improve prognosis.
• Beta-blockers: Slow the heart rate and protect the heart muscle.
• Diuretics: Reduce fluid retention and relieve cardiac strain.
• Aldosterone antagonists: Improve outcomes in patients with severe heart failure.
• SGLT2 inhibitors: Newer agents that have been shown to reduce hospitalizations and mortality.
• Digoxin: May improve cardiac output in selected patients.

Non-Pharmacological Measures

• Low-sodium diet and fluid intake monitoring.
• Regular, tailored physical activity and cardiac rehabilitation.
• Weight management and smoking cessation.
• Reduction or complete avoidance of alcohol consumption.

Interventional and Surgical Therapy

• ICD implantation (implantable cardioverter-defibrillator) for patients at high risk of life-threatening arrhythmias.
• CRT (cardiac resynchronization therapy) for impaired electrical conduction within the heart.
• Heart transplantation in cases of refractory severe heart failure.
• Mechanical circulatory support (e.g., LVAD -- left ventricular assist device) as a bridge to transplantation or as long-term therapy.

Prognosis and Outlook

Cardiac muscle insufficiency is a chronic condition that generally cannot be fully cured. However, with consistent and optimized treatment, disease progression can be significantly slowed and quality of life greatly improved. Regular cardiological follow-up is essential to detect deterioration early and adjust therapy accordingly.

References

1. McDonagh T.A. et al. - 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 2021.
2. Ponikowski P. et al. - 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 2016.
3. American Heart Association - Heart Failure. www.heart.org, 2023.